VentriPoint Diagnostics Ltd (VPTDF)
0.167
+0.01
(+4.29%)
USD |
OTCM |
May 31, 16:00
VentriPoint Diagnostics Enterprise Value: 25.32M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 25.32M |
| May 30, 2024 | 24.24M |
| May 29, 2024 | 24.16M |
| May 28, 2024 | 24.80M |
| May 24, 2024 | 25.91M |
| May 23, 2024 | 25.26M |
| May 22, 2024 | 27.83M |
| May 21, 2024 | 27.83M |
| May 20, 2024 | 26.48M |
| May 17, 2024 | 24.60M |
| May 16, 2024 | 25.79M |
| May 15, 2024 | 25.79M |
| May 14, 2024 | 26.49M |
| May 13, 2024 | 28.77M |
| May 10, 2024 | 29.24M |
| May 09, 2024 | 28.61M |
| May 08, 2024 | 28.06M |
| May 07, 2024 | 28.66M |
| May 06, 2024 | 33.02M |
| May 03, 2024 | 26.87M |
| May 02, 2024 | 25.29M |
| May 01, 2024 | 26.13M |
| April 30, 2024 | 23.91M |
| April 29, 2024 | 26.10M |
| April 26, 2024 | 25.16M |
| Date | Value |
|---|---|
| April 25, 2024 | 25.00M |
| April 24, 2024 | 24.20M |
| April 23, 2024 | 25.41M |
| April 22, 2024 | 24.72M |
| April 19, 2024 | 24.55M |
| April 18, 2024 | 24.02M |
| April 17, 2024 | 25.00M |
| April 16, 2024 | 24.44M |
| April 15, 2024 | 25.00M |
| April 12, 2024 | 23.44M |
| April 11, 2024 | 25.47M |
| April 10, 2024 | 24.20M |
| April 09, 2024 | 25.00M |
| April 08, 2024 | 25.73M |
| April 05, 2024 | 26.67M |
| April 04, 2024 | 26.64M |
| April 03, 2024 | 27.26M |
| April 02, 2024 | 26.10M |
| April 01, 2024 | 26.42M |
| March 28, 2024 | 26.70M |
| March 27, 2024 | 25.49M |
| March 26, 2024 | 26.64M |
| March 25, 2024 | 26.78M |
| March 22, 2024 | 26.48M |
| March 21, 2024 | 27.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.6123M
Minimum
Apr 24 2020
65.49M
Maximum
May 24 2021
24.76M
Average
26.58M
Median
Oct 05 2022
Enterprise Value Benchmarks
| Delcath Systems Inc | 176.13M |
| Star Equity Holdings Inc | 14.38M |
| Exact Sciences Corp | 10.10B |
| CytoSorbents Corp | 44.70M |
| Progyny Inc | 2.194B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.9087M |
| Revenue (Quarterly) | 0.0304M |
| Total Expenses (Quarterly) | 0.942M |
| EPS Diluted (Quarterly) | -0.0073 |
| Gross Profit Margin (Quarterly) | 99.95% |
| Profit Margin (Quarterly) | -2.99K% |
| Earnings Yield | -17.74% |
| Normalized Earnings Yield | -17.69 |